ABSTRACT The diabetogenic agent alloxan exerts a preferential cytotoxic effect on the pancreatic B cell. The determinants of such a tissue specificity were investigated. Alloxan accumulated rapidly in liver and pancreatic islets but much more slowly in muscle. The activity of glutathione peroxidase and the resistance to exogenous peroxide were -20 times higher in liver and kidney than in islets, intermediate values being found in exocrine pancreas and muscle. These findings suggest that the selective cytotoxicity of alloxan to the pancreatic B cell is attributable to the conjunction oftwo features: a rapid cellular uptake ofthe drug and an exquisite sensitivity of the B cell to peroxide.
Alloxan has been known for about four decades to induce diabetes mellitus in animals by causing a rather selective necrosis ofinsulin-producing cells (1, 2) . There is evidence that the generation of hydrogen peroxide, superoxide anion radicals, and hydroxyl radicals plays a critical role in the cytotoxicity ofalloxan (3) (4) (5) (6) . However, there was so far no biochemical explanation for the selectivity of this cytotoxic action toward the pancreatic B cell. We have investigated the determinants of such selectivity from a double standpoint. First, we have explored whether different tissues vary from one another by their capacity to accumulate alloxan. Second, we have assessed their sensitivity to peroxide radicals by treating them with various concentrations of tert-butyl hydroperoxide (tert-BuOOH).
MATERIALS AND METHODS
Yeast glutathione reductase (EC 1.6.4.2) was purchased from Boehringer (Mannheim, Federal Republic ofGermany), alloxan was from Sigma, tert-BuOOH was from Aldrich-Europe (Beerse, Belgium), ['4C ]urea and [6,6' (n)-3H]sucrose were from the Radiochemical Centre (Amersham, England), D-[U-'4C]glucose was from New England Nuclear (Boston, MA), and [2-'4C]alloxan was from California Bionuclear (Sun Valley, CA). The latter preparation contained 9.2% alloxanic acid, as judged by TLC (7) .
All experiments were carried out with tissues removed from fed albino rats. The incubation medium was a bicarbonate buffered solution (139 mM Na+/5 mM K+/1 mM Ca2+/1 mM Mg2+/24 mM HCO37/124 mM C1-) containing bovine albumin (5 mg/ml) and equilibrated against 95% 0J5% CO2 (vol/vol). The methods used to measure reduced and oxidized glutathione (GSH and GSSG, respectively) (8), glucose oxidation (9) , and insulin release (10) [6,6' (n)-3H]sucrose (0.6 mM) after previous incubation ofthe tissues for 30 min at 230C in a glucose-free nonradioactive medium containing sucrose (0.6 mM). After incubation, the islets (incubated in groups of30 islets each in 0.1 ml of medium) were separated from the incubation medium by centrifugating the latter through a layer ofdi-n-butyl phthalate (11), whereas liver slices (10.1 ± 0.5 mg; n = 48) or hemidiaphragms (155.8 ± 8.9 mg; n = 19) were separated from the medium on a Millipore filter. The radioactivity ofthe tissue samples was determined by liquid scintillation assay in Instafluor II (Packard, Downers Grove, IL.) or Lumagel (Lumac, Basel, Switzerland), the liver and muscle samples being first digested overnight in hyamine hydroxide (Packard). The radioactivity of the incubation medium was examined under identical conditions (i. For measuring GSH peroxidase activity (EC 1.11.1.9), tissue samples (1000 islets, 5 mg of diaphragm, 1.5 mg of pancreas, or 0.5 mg of kidney or liver) were sonicated (twice, 5 sec each; islets, liver) or homogenized by hand (diaphragm, pancreas, kidney) in 1.0 ml of the usual incubation medium (except for the absence of albumin). After centrifugation (15 min, 4°C, 800 x g), samples ofthe homogenate were brought to a final volume of 0.1 ml in (final concentrations) 250 mM Na2HPOJHCl buffer, pH 7.0/4 mM EDTA/4 mM nicotinamide/2 mM Na3N/ 3 mM GSH/0.75 mM NADPH/containing GSSG reductase at 5 jig/ml and 0.5 mM tert-BuOOH, which was added to initiate the reaction. After 15 min of incubation at room temperature, the reaction was halted by addition of0.3 ml of0.3 M HCL. The NADP+ formed was converted to a fluorescent product by incubation for 10 min at 60°C with 1.0 ml of6 M NaOH. NADP+ (2.5-25 nmol) and GSSG (2.5-10 nmol) standards were treated in exactly the same manner throughout the procedure and yielded linear dose-related responses. Neither tert-BuOOH nor the islet homogenate (in the absence of tert-BuOOH) affected the readings obtained with these standards. The readings obtained with the tissue samples were corrected for both the blank value found in the absence of tissue and tert-BuOOH and the Abbreviations: tert-BuOOH, tert-butyl hydroperoxide; GSSG and GSH, oxidized glutathione and reduced glutathione, respectively. 927
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All results are presented as mean ± SEM. RESULTS Alloxan decreased the GSH content and inhibited both glucose oxidation and glucose-stimulated insulin release in pancreatic islets (Table 1) . These effects were mimicked by tert-BuOOH (Table l) . During 90 min of incubation at 370C, H202 (0.2 mM) decreased insulin release evoked by glucose (16.7 mM) from the control value of 287 ± 29 to 123 ± 24 (microunits/90 min) per islet (n = 8 for both groups; P<0.001).
As shown in Table 2 , when islets were incubated for 5 min at 230C, the distribution space of [2-14C] contrast to that of alloxan, was unlikely to display any marked tissue specificity. Agents, such as tert-BuOOH, that affect the redox state may either increase or decrease D-[U-'4C]glucose oxidation. This dual effect does not depend solely on the balance between oxidation in the pentose shunt and the Krebs cycle (16) ; it has also been observed with nutrients such as L-[U-
'4C]glutamine (data not shown). Therefore, the sensitivity to tert-BuOOH was judged from the changes in glucose oxidation, independently of whether they consisted of an increase or a decrease in 14Co2 output. As little as 0.2 mM tert-BuOOH was sufficient to cause a 50% decrease in glucose oxidation by islets (Fig. 1) . The concentration oftert-BuOOH had to reach 0.5 and 2.0 mM, respectively, to significantly affect glucose oxidation in muscle and exocrine pancreas. Kidney and liver were even more resistant to tert-BuOOH, requiring a concentration of5.0 mM to alter glucose oxidation. There was a close correlation (r = 0.942; P < 0.02) between the activity of GSH peroxidase in each tissue and the lowest concentration of tert-BuOOH affecting significantly glucose oxidation in the same tissue ( Table  2 ). There was also a significant correlation (r = 0.947; P < 0.02) between the relative magnitude (percent decrease) of the inhibitory action of tert-BuOOH on glucose oxidation by pancreatic islets and the concentration of glucose (2.8-27.8 mM) present in the preincubation and incubation media (data not shown). In other words, glucose protected the islet cells against the inhibitory action of tert-BuOOH in a dose-related fashion.
DISCUSSION
Our results show that alloxan decreases the islet GSH content and confirm that alloxan inhibits glucose oxidation (17) and glucose-stimulated insulin release (18) by pancreatic islets. These functional effects of alloxan are presumably relevant to the cytotoxic action of the drug. They were qualitatively reproduced by tert-BuOOH, a finding consistent with the view that the cytotoxicity of alloxan is related to the generation of peroxides (3) (4) (5) (6) .
Glucose, which protects islet cells against the inhibitory action ofalloxan on both glucose oxidation and insulin release (17, 18) and increases the generation rate of reducing equivalents (16) , also protected the islet cells against the inhibitory action of tert-BuOOH on glucose oxidation. The effect of alloxan on islet function was examined after prior incubation at 4°C in the absence of glucose to avoid both the inactivation of alloxan and the protective effect of glucose. In examining the sensitivity to tert-BuOOH, all tissues were first incubated at 37°C in the presence of glucose so that both incubations were carried out under identical conditions and, hence, the oxidation of glucose was measured in a close-to-steady state.
It is unlikely that the specific toxicity of alloxan to the B cell is accounted for solely by the cellular uptake of the drug (7, 19) because alloxan accumulates at least as rapidly and extensively in liver as in islets (20, 21) . Nevertheless, the uptake of alloxan may be required for the cytotoxic effect. Thus, a low rate of alloxan uptake may explain why certain tissues other than islets are little affected by the diabetogenic agent. In this respect, there appear to exist definite analogies between glucose and alloxan transport. For instance, alloxan is slowly taken up by muscle, in which glucose transport is a rate-limiting step of its metabolism. Such is not the case in hepatocytes or B cells (14, 15, 22) . These analogies should be considered in light of the structural similarity between alloxan and D-glucose, as judged by stereospecific criteria (23) . They may also account for the resistance to alloxan of non-B-islet cells such as the glucagonproducing cell, in which glucose transport apparently represents a rate-limiting and insulin-sensitive process (24) (25) (26) .
In search of a second factor conditioning the sensitivity to alloxan, we have measured in several tissues the activity ofGSH peroxidase, an enzyme catalyzing the reduction of peroxides. The activity was much less in islets than in other tissues, in good agreement with recent data obtained in our laboratory by a different technique (27) . To assess the functional significance of the difference in peroxidase activity, we have examined the sensitivity of intact cells to tert-BuOOH, the substrate used in the measurement of peroxidase activity in tissue homogenates. There was a close correlation between these two series of determinations.
These findings suggest that the selective cytotoxicity of alloxan to the pancreatic B cell results from the coincidence oftwo features: a rapid cellular uptake of the drug, also seen in liver, and an exquisite sensitivity to peroxide, itselfattributable to low peroxidase activity (GSH peroxidase, catalase). This interpretation is further supported by the observation that islets removed from guinea pigs, which are more resistant than rats to the diabetogenic action of alloxan (28) , are 1/5 as sensitive as rat islets to tert-BuOOH (29) .
